| [1] |
Egeberg O. On the natural blood coagulation inhibitor system. Investigations of inhibitor factors based on antithrombin deficient blood[J]. Thromb Diath Haemorrh, 1965，14(3-4): 473-489.
|
| [2] |
王鸿利. 血液学和血液学检验[M]. 2版. 北京：人民卫生出版社，1997: 292-293.
|
| [3] |
Lu Y, Zhao Y, Liu G, et al. Factor V gene G1691A mutationprothrombin gene G20210A and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population[J]. Thromb Res, 2002, 106(1):7-12.
|
| [4] |
Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis[J]. Blood, 1996, 88(10):3698-3703.
|
| [5] |
Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy[J]. N-Engl-J-Med, 1999, 340(1):9-13.
|
| [6] |
Lockwood C, Wendel G. Committee on Practice Bulletins-Obstetrics.Practice bulletin no.124：inherited thrombophilias in pregnancy[J]. Obstet Gynecol, 2011, 118(3):730-740.
|
| [7] |
Simioni P, Prandoni P, Burlina A, et al. Hyperhomocysteinemia and deep-vein thrombosis：a case-control study[J]. Thromb Haemost, 1996, 76(6):883-886.
|
| [8] |
Nelen WL, Blom HJ, Steegers EA, et al. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis[J]. Fertil Steril, 2000, 74(6):1196-1199.
|
| [9] |
Peng F, Labelle LA, Rainey BJ, et al. Single nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene are common in US Caucasian and Hispanic American populations[J]. Int J Mol Med, 2001, 8(5):509-511.
|
| [10] |
Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies[J]. J Thromb Haemost, 2005, 3(2):292-299.
|
| [11] |
Griffin JH, Evatt B, Zimmerman TS, et al. Deficiency of protein C in congenital thrombotic disease[J]. J Clin Invest, 1981, 68(5):1370-1373.
|
| [12] |
贺立山. 血液病家族新成员-易栓症[J]. 医学新知杂志，2008, 18(3):129-133.
|
| [13] |
刘丽，贺立山，杨爽，等. 遗传性蛋白S缺陷症一个新的基因突变[J]. 中华血液学杂志，2001, 22(9):457-460.
|
| [14] |
Blumenfeld Z, Brenner B. Thrombophilia-associated pregnancy wastage[J]. Fertil Steril, 1999, 72(5):765-774.
|
| [15] |
Bremme KA. Hemostatia changes in pregnancy[J]. Ballieres Best Pract Res Clin Hameatol, 2003, 16(2):153-168.
|
| [16] |
林建华. 妊娠期易栓症的处理[J]. 实用妇产科杂志，2009, 25(3):142-144.
|
| [17] |
Brenner B. Clinical management of thrombophila-related placental vascular complications [J]. Blood, 2004, 103(11):4003-4009.
|
| [18] |
Dekker G. Underlying disorders associated with severe early-onset preeclampsia[J]. Am J Obstet Gynecol, 1995, 173(4):1042-1048.
|
| [19] |
Edmund F, Funai MD. Inherited thrombophilia and preeclampsia：is the evidence beginning to congeal[J]. Am J Obstet Gynecol, 2009, 200(2):121-122.
|
| [20] |
Lim W, Eikelboom JW, Ginsberg JS. Inherited thrombophilia and pregnancy associated venous thromboembolism[J]. BMJ, 2007, 334(7607):1318-1321.
|
| [21] |
Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus[J]. Obstet Gynecol, 2005, 106(3):517-524.
|
| [22] |
Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2002, 101(1):6-14.
|
| [23] |
Chauhan SP, Berghella V, Sanderson M, et al. American college of obstetricians and gynecologists practice bulletins：an overview[J]. Am J Obstet Gynecol, 2006, 194(6):1564-1572.
|
| [24] |
Adi Y, Weintraub, Eyal Sheiner, et al. Pregnancy complications in women with inherited thrombophilia [J]. ArchGynecol Obstet, 2006, 274(3):125-129.
|
| [25] |
Facco F, You W, Grobman W. Genetic thrombophilias and intrauterine growth restriction[J]. Obstet Gyneco, 2009, 113(6):1206-1216.
|
| [26] |
Howley HE, Walker M, Rodger MA. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction[J]. Am J Obstet Gynecol, 2005, 192(3):694-708.
|
| [27] |
Infante-Rivard C, Rivard GE, Yotov WV, et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction[J]. N Engl J Med 2002, 347(1):19-25.
|
| [28] |
Wang X, Ma Z, Lin Q．Inherited thrombophilia in recurrent spontaneous abortion among Chinese women[J]. Int J Gynaecol Obstet, 2006, 92(3):264-265.
|
| [29] |
Kovalevsky G, Gracia CR, Berlin JA, et al. Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss：a meta-analysis[J]. Arch Intern Med, 2004，164(5):558-563.
|
| [30] |
Facchinetti F, Marozio L, Grandone E, et al. Thrombophilic mutations are a main risk factor for placental abruption[J]. Haematologica, 2003, 88(7):785-788.
|
| [31] |
Favaloro EJ. Diagnostic issues in thrombophilia：a laboratory seientist’s view[J]. Semin Thromb Hemost, 2005, 31(l):11-16.
|
| [32] |
Harenberg J, Schneider D, Heilmann L, et al. Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women[J]. Haemostasis, 1993, 23(6):314-320.
|
| [33] |
Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy：a systematic review of safety and efficacy[J]. Blood, 2005, 106(2):401-407.
|
| [34] |
James AH, Abel DE, Brancazio LR. Anticoagulants in pregnancy[J]. Obstet Gynecol Surv, 2006, 61(1):59-69.
|
| [35] |
Fox NS, Laughon SK, Bender SD, et al. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis[J]. Obstet Gynecol, 2008, 112(4):884-889.
|
| [36] |
Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy [J]. Chest, 1995, 108(4):305-311.
|
| [37] |
Iturbe-Alessio I, Fonseca MC, Mutchinik O, et al. Risks of anticoagulant therapy in pregnant women with artificial heart valves[J]. N Engl J Med, 1986, 315(22):1390-1393.
|